Par Pharmaceutical (PRX +0.2%) says that its operating subsidiary has begun shipping 5 mg and 10...

|About: Par Pharmaceutical Companie... (PRX)|By:, SA News Editor

Par Pharmaceutical (PRX +0.2%) says that its operating subsidiary has begun shipping 5 mg and 10 mg strengths of rizatriptan benzoate tablets. Rizatriptan benzoate is indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age. Annual U.S. sales of the drug total approximately $653M.